| (Mark One)                                                                                                                                             |
|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| [X]                                                                                                                                                    | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |
| For the quarterly period ended:  September 30, 2010                                                                                          |
| Or                                                                                                                                                |
| [  ]                                                                                                                                              | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|                                                                                                                                                   |
| Commission File No. 000-53298                                                                                                                     |
| ATLAS THERAPEUTICS CORPORATION(Exact name of small business issuer as specified in its charter)                                                        |
|                                                                                                                                                   |
| Nevada(State or other jurisdiction of incorporation or organization)                                                                                   | 000-53298(I.R.S. Employer Identification No.) |
|                                                                                                                                                   |   |
|  11759 Crystal Avenue, Chino, CA 91710(Address of Principal Executive Offices) (909) 465-1030(Issuer’s telephone number)               |
|                                                                                                                                                   |
| Marvin’s Place, Inc.8860 Greenlawn Street, Riverside, CA 92508(Former name, former address and former fiscal year, if changed since last report) |
|                                                                                                                                                   |

| [   ]  Large accelerated filer | [   ]  Accelerated filer |
|---------------------------------------------------------|----------------------------------------------|
| [   ]  Non-accelerated filer   | [X]  Smaller reporting company     |

----

| INDEX                                                                                                                                                                          | Page   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                                                                                                           |   |
| PART 1-FINANCIAL INFORMATION                                                                                                                                                   | 2      |
|                                                                                                                                                                           |   |
| Item 1.  Financial Statements                                                                                                                                        |   |
| Balance Sheets as of September 30, 2010 (unaudited) and December 31, 2009                                                                                                      | F-1    |
|                                                                                                                                                                           |   |
| Statements of Operations (unaudited) for the nine months ended September 30, 2010 and September 30, 2009 and the period from inception (April 11, 2007) to September 30, 2010. | F-2    |
|                                                                                                                                                                           |   |
| Statements of Cash Flows (unaudited) for the nine months ended September 30, 2010 and September 30, 2009 and the period from inception (April 11, 2007) to September 30, 2010  | F-3    |
|                                                                                                                                                                           |   |
| Notes to Financial Statements                                                                                                                                                  | F-4    |
|                                                                                                                                                                           |   |
| Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations                                                                 | 3      |
|                                                                                                                                                                           |   |
| Item 3.  Quantitative and Qualitative Disclosures about Market Risk                                                                                                  | 4      |
|                                                                                                                                                                           |   |
| Item 4.  Control and Procedures                                                                                                                                      | 4      |
|                                                                                                                                                                           |   |
| PART II-OTHER INFORMATION                                                                                                                                                      | 5      |
|                                                                                                                                                                           |   |
| Item 1.  Legal Proceedings                                                                                                                                           | 5      |
|                                                                                                                                                                           |   |
| Item 1A.  Risk Factors                                                                                                                                               | 5      |
|                                                                                                                                                                           |   |
| Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                 | 7      |
|                                                                                                                                                                           |   |
| Item 3.  Defaults Upon Senior Securities                                                                                                                             | 7      |
|                                                                                                                                                                           |   |
| Item 4.  Submission of Matters to a Vote of Security Holders                                                                                                         | 8      |
|                                                                                                                                                                           |   |
| Item 5.  Other Information                                                                                                                                           | 8      |
|                                                                                                                                                                           |   |
| Item 6.  Exhibits                                                                                                                                                    | 8      |
|                                                                                                                                                                           |   |
| SIGNATURES                                                                                                                                                                     | 9      |

PART

Item

----

BALANCE

| ASSETS                                                   |   |          |     |   |         |   |
|----------------------------------------------------------|--------|---------------|----------|--------|--------------|--------|
|                                                     |   | September 30, |     |   | December 31, |   |
|                                                     |   | 2010          |     |   | 2009         |   |
|                                                     |   | (unaudited)   |     |   |         |   |
|                                                     |   |          |     |   |         |   |
| CURRENT ASSETS                                           |   |          |     |   |         |   |
|                                                     |   |          |     |   |         |   |
| Cash                                                     |   | $             | 14       |   |         | $      | 145 |   |
|                                                     |   |          |     |   |         |   |   |   |
| Total Current Assets                                     |   |          | 14       |   |         |   | 145 |   |
|                                                     |   |          |     |   |         |   |   |   |
| TOTAL ASSETS                                             |   | $             | 14       |   |         | $      | 145 |   |
|                                                     |   |          |     |   |         |   |   |   |
|                                                     |   |          |     |   |         |   |   |   |
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)           |   |          |     |   |         |   |   |   |
|                                                     |   |          |     |   |         |   |   |   |
| CURRENT LIABILITIES                                      |   |          |     |   |         |   |   |   |
|                                                     |   |          |     |   |         |   |   |   |
| Accounts payable and accrued expenses                    |   | $             | 12,986   |   |         | $      | 20,100 |   |
| Accounts payable related party                           |   |          | 32,511   |   |         |   | 17,466 |   |
| Note payable                                             |   |          | 7,500    |   |         |   | - |   |
|                                                     |   |          |     |   |         |   |   |   |
| Total Current Liabilities                                |   |          | 52,997   |   |         |   | 37,566 |   |
|                                                     |   |          |     |   |         |   |   |   |
| STOCKHOLDERS' EQUITY (DEFICIT)                           |   |          |     |   |         |   |   |   |
|                                                     |   |          |     |   |         |   |   |   |
| Preferred stock, 25,000,000 shares authorized            |   |          |     |   |         |   |   |   |
|    at par value of $0.001, no shares      |   |          |     |   |         |   |   |   |
|    issued and outstanding                 |   |          | -        |   |         |   | - |   |
| Common stock, 300,000,000 shares authorized              |   |          |     |   |         |   |   |   |
|   at par value of $0.001 per share, 49,000,000 |   |          |     |   |         |   |   |   |
|   shares issued and outstanding                |   |          | 49,000   |   |         |   | 49,000 |   |
| Additional paid-in capital                               |   |          | 31,000   |   |         |   | 31,000 |   |
| Deficit accumulated during the development stage         |   |          | (132,983 | )      |         |   | (117,421 | ) |
|                                                     |   |          |     |   |         |   |   |   |
| Total Stockholders' Equity (Deficit)                     |   |          | (52,983  | )      |         |   | (37,421 | ) |
| TOTAL LIABILITIES AND                                    |   |          |     |   |         |   |   |   |
|    STOCKHOLDERS' EQUITY (DEFICIT)         |   | $             | 14       |   |         | $      | 145 |   |

----

INTERIM

|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   | From           |       |
|-----------------------------------------|--------|----------------------------|------------|--------|---------------------------|--------|------------|---------------|--------|--------|------------|--------|--------|----------------|------------|
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   | Inception on   |       |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   | April 11, 2007 |       |
|                                    |   | For the Three Months Ended |       |   | For the Nine Months Ended |   |       | Through       |   |
|                                    |   | September 30,              |       |   | September 30,             |   |       | September 30, |   |
|                                    |   | 2010                       |       |   | 2009                      |   |       | 2010          |   |   | 2009       |   |   | 2010           |       |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |
| REVENUES                                |   | $                          | -          |   |                      | $      | -          |          |   | $      | -          |   |   | $              | -          |   |   | $ | - |   |
| COST OF SALES                           |   |                       | -          |   |                      |   | -          |          |   |   | -          |   |   |           | -          |   |   |   | - |   |
| GROSS MARGIN                            |   |                       | -          |   |                      |   | -          |          |   |   | -          |   |   |           | -          |   |   |   | - |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| OPERATING EXPENSES                      |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| General and administrative              |   |                       | 2,416      |   |                      |   | 3,144      |          |   |   | 27,926     |   |   |           | 16,782     |   |   |   | 145,347 |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| Total Operating Expenses                |   |                       | 2,416      |   |                      |   | 3,144      |          |   |   | 27,926     |   |   |           | 16,782     |   |   |   | 145,347 |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| LOSS FROM OPERATIONS                    |   |                       | (2,416     | )      |                      |   | (3,144     | )             |   |   | (27,926    | )      |   |           | (16,782    | ) |   |   | (145,347 | ) |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| OTHER INCOME                            |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| Interest expense                        |   |                       | (94        | )      |                      |   | -          |          |   |   | (136       | )      |   |           | -          |   |   |   | (136 | ) |
| Gain on forgiveness of debt             |   |                       | -          |   |                      |   | -          |          |   |   | 12,500     |   |   |           | -          |   |   |   | 12,500 |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| Total Other Income                      |   |                       | (94        | )      |                      |   | -          |          |   |   | 12,364     |   |   |           | -          |   |   |   | 12,364 |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| NET  LOSS BEFORE INCOME TAXES |   |                       | (2,510     | )      |                      |   | (3,144     | )             |   |   | (15,562    | )      |   |           | (16,782    | ) |   |   | (132,983 | ) |
| INCOME TAX EXPENSE                      |   |                       | -          |   |                      |   | -          |          |   |   | -          |   |   |           | -          |   |   |   | - |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| NET LOSS                                |   | $                          | (2,510     | )      |                      | $      | (3,144     | )             |   | $      | (15,562    | )      |   | $              | (16,782    | ) |   | $ | (132,983 | ) |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| BASIC  LOSS PER SHARE         |   | $                          | (0.00      | )      |                      | $      | (0.00      | )             |   | $      | (0.00      | )      |   | $              | (0.00      | ) |   |   |   |   |
|                                    |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
| WEIGHTED AVERAGE NUMBER                 |   |                       |       |   |                      |   |       |          |   |   |       |   |   |           |       |   |   |   |   |   |
|   OF SHARES OUTSTANDING       |   |                       | 49,000,000 |   |                      |   | 49,000,000 |          |   |   | 49,000,000 |   |   |           | 49,000,000 |   |   |   |   |   |

----

STATEMENTS

|                                               |   |                      |    |   |          |   |    | From           |   |
|----------------------------------------------------|--------|---------------------------|---------|--------|---------------|--------|---------|----------------|--------|
|                                               |   |                      |    |   |          |   |    | Inception on   |   |
|                                               |   |                      |    |   |          |   |    | April 11, 2007 |   |
|                                               |   | For the Nine Months Ended |    |   | Through       |   |
|                                               |   | September 30,             |    |   | September 30, |   |
|                                               |   | 2010                      |    |   | 2009          |   |    | 2010           |   |
|                                               |   |                      |    |   |          |   |    |           |   |
|                                               |   |                      |    |   |          |   |    |           |   |
| OPERATING ACTIVITIES                               |   |                      |    |   |          |   |    |           |   |
|                                               |   |                      |    |   |          |   |    |           |   |
| Net income (loss)                                  |   | $                         | (15,562 | )      |          | $      | (16,782 | )              |   | $ | (132,983 | ) |
| Adjustments to reconcile net loss to               |   |                      |    |   |          |   |    |           |   |   |   |   |
|   net cash used by operating activities: |   |                      |    |   |          |   |    |           |   |   |   |   |
| Common stock issued for services                   |   |                      | -       |   |          |   | -       |           |   |   | - |   |
| Changes in operating assets and liabilities:       |   |                      |    |   |          |   |    |           |   |   |   |   |
| Increase (decrease) in accounts payable            |   |                      | (7,114  | )      |          |   | (1,000  | )              |   |   | 12,986 |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| Net Cash Used in Operating Activities              |   |                      | (22,676 | )      |          |   | (17,782 | )              |   |   | (119,997 | ) |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| INVESTING ACTIVITIES                               |   |                      | -       |   |          |   | -       |           |   |   | - |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| FINANCING ACTIVITIES                               |   |                      |    |   |          |   |    |           |   |   |   |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| Proceeds from common stock issued                  |   |                      | -       |   |          |   | -       |           |   |   | 80,000 |   |
| Increase (decrease) in advances from               |   |                      |    |   |          |   |    |           |   |   |   |   |
|   related parties                        |   |                      | 22,545  |   |          |   | 14,966  |           |   |   | 40,011 |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| Net Cash Provided by Financing Activities          |   |                      | 22,545  |   |          |   | 14,966  |           |   |   | 120,011 |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| NET INCREASE (DECREASE) IN CASH                    |   |                      | (131    | )      |          |   | (2,816  | )              |   |   | 14 |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| CASH AT BEGINNING OF PERIOD                        |   |                      | 145     |   |          |   | 2,887   |           |   |   | - |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| CASH AT END OF PERIOD                              |   | $                         | 14      |   |          | $      | 71      |           |   | $ | 14 |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| SUPPLEMENTAL CASH FLOW INFORMATION:                |   |                      |    |   |          |   |    |           |   |   |   |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| CASH PAID FOR:                                     |   |                      |    |   |          |   |    |           |   |   |   |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| Interest                                           |   | $                         | -       |   |          | $      | -       |           |   | $ | - |   |
| Income taxes                                       |   | $                         | -       |   |          | $      | -       |           |   | $ | - |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| NON CASH FINANCING ACTIVITIES                      |   |                      |    |   |          |   |    |           |   |   |   |   |
|                                               |   |                      |    |   |          |   |    |           |   |   |   |   |
| Note issued for accounts payable                   |   | $                         | 7,500   |   |          | $      | -       |           |   | $ | 7,500 |   |

----

Notes

----

----

----

Item

----

ITEM

ITEM

----

PART

ITEM 

ITEM

----

----

ITEM

ITEM

----

ITEM

ITEM

ITEM

| No.    | Description of Exhibit                                                                                                                 |
|--------|----------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                   |
| 31.1   | Certification of Principal Executive Officer/Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002     |
|   |                                                                                                                                   |
| 32.1   | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act 0f 2002 |

----

SIGNATURES

|                               | Atlas Therapeutics Corporation |
|------------------------------------|--------------------------------|
|                               |                           |
|                               |                           |
| Date:  November 12, 2010 | By: /s/ Georgette Mathers |
|                               | Georgette Mathers              |
|                               | Chief Executive Officer        |

| Signature             | Title(s)                                     | Date              |
|-----------------------|----------------------------------------------|-------------------|
|                  |                                         |              |
| /s/ Georgette Mathers | Chief Executive Officer and Director         | November 12, 2010 |
| Georgette Mathers     | (Principal Executive Officer)                |              |
|                  |                                         |              |
| /s/ Georgette Mathers | Chief Financial Officer and Director         | November 12, 2010 |
| Georgette Mathers     | (Principal Financial and Accounting Officer) |              |

----